Aditi Dutt

Array ( [id] => 5398306 [patent_doc_number] => 20090318369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'BIOMARKERS FOR ALZHEIMER\'S DISEASE AND METHODS USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/192469 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18517 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318369.pdf [firstpage_image] =>[orig_patent_app_number] => 12192469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639321 [patent_doc_number] => 08017348 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-09-13 [patent_title] => 'Assay for Parkinson\'s Disease therapeutics' [patent_app_type] => utility [patent_app_number] => 12/177100 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 12689 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017348.pdf [firstpage_image] =>[orig_patent_app_number] => 12177100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292296 [patent_doc_number] => 20100239528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta' [patent_app_type] => utility [patent_app_number] => 12/669893 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6927 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239528.pdf [firstpage_image] =>[orig_patent_app_number] => 12669893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 170417 [patent_doc_number] => 07662626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Cells and methods for estimation of effects on neurological dysfunction' [patent_app_type] => utility [patent_app_number] => 12/143202 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6254 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662626.pdf [firstpage_image] =>[orig_patent_app_number] => 12143202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6626985 [patent_doc_number] => 20100172919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'NOVELTREATMENT FOR NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/664540 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14286 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172919.pdf [firstpage_image] =>[orig_patent_app_number] => 12664540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508500 [patent_doc_number] => 20090081707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Human trk receptors and neurotrophic factor inhibitors' [patent_app_type] => utility [patent_app_number] => 12/157753 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 34207 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081707.pdf [firstpage_image] =>[orig_patent_app_number] => 12157753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10147900 [patent_doc_number] => 09180165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Use of EPO receptor activation or stimulation for the improvement of the EDSS score in patients with multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 12/136509 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13025 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12136509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10649399 [patent_doc_number] => 09365634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues' [patent_app_type] => utility [patent_app_number] => 12/601803 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 40 [patent_no_of_words] => 24208 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12601803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959668 [patent_doc_number] => 20080274093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'METHOD OF DIMINISHING THE SYMPTOMS OF NEURODEGENERATIVE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/111709 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10134 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274093.pdf [firstpage_image] =>[orig_patent_app_number] => 12111709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950555 [patent_doc_number] => 20130196336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'TRANSGLUTAMINASE 6 AS A DIAGNOSTIC INDICATOR OF AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/594926 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13929 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159704 [patent_doc_number] => 07674890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Stem cell factor-like proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/080212 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35300 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674890.pdf [firstpage_image] =>[orig_patent_app_number] => 12080212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10045365 [patent_doc_number] => 09085754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Isolated population of cells and methods of generating and using same' [patent_app_type] => utility [patent_app_number] => 12/450515 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 12172 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12450515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765114 [patent_doc_number] => 20080176325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Method for Obtaining and Storing Multipotent Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/047563 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3433 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176325.pdf [firstpage_image] =>[orig_patent_app_number] => 12047563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740544 [patent_doc_number] => 20080234197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF)' [patent_app_type] => utility [patent_app_number] => 12/075084 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234197.pdf [firstpage_image] =>[orig_patent_app_number] => 12075084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4848 [patent_doc_number] => 07812126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'DIRS1 polypeptides' [patent_app_type] => utility [patent_app_number] => 12/042165 [patent_app_country] => US [patent_app_date] => 2008-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22489 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812126.pdf [firstpage_image] =>[orig_patent_app_number] => 12042165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4821965 [patent_doc_number] => 20080227201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'In vitro model for neuronal death' [patent_app_type] => utility [patent_app_number] => 12/013921 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7742 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227201.pdf [firstpage_image] =>[orig_patent_app_number] => 12013921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6398039 [patent_doc_number] => 20100178652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease' [patent_app_type] => utility [patent_app_number] => 12/522155 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14083 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178652.pdf [firstpage_image] =>[orig_patent_app_number] => 12522155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10881991 [patent_doc_number] => 08906367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Method of providing disease-specific binding molecules and targets' [patent_app_type] => utility [patent_app_number] => 12/522031 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 43430 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12522031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251691 [patent_doc_number] => 20100028297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/520045 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16575 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028297.pdf [firstpage_image] =>[orig_patent_app_number] => 12520045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574009 [patent_doc_number] => 20100129319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'TREATMENT OF DISEASE OR INJURY OF THE NERVOUS SYSTEM USING AGENTS THAT DECREASE THE ACTIVITY OF THE MELANOCORTIN 4 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/518761 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14981 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129319.pdf [firstpage_image] =>[orig_patent_app_number] => 12518761 [rel_patent_id] =>[rel_patent_doc_number] =>)